Septodont Holding
Septodont Holding, a family-owned pharmaceutical and medical device company based in France, is recognized as the world leader in the dental anesthesia market, holding the largest market share in 2024. With a history of excellence in dental care, the company is dedicated to pain control, endodontics, and restorative dentistry, serving dental and healthcare professionals in over 150 countries. Septodont’s core competency lies in the manufacturing and distribution of high-quality local anesthetics, producing approximately 500 million anesthetic cartridges annually. Their comprehensive portfolio includes injectable and topical anesthetics, dental needles, safety syringes, and innovative delivery systems like the Dentapen electronic syringe. Key product offerings include Septocaine® (USA’s #1 branded dental local anesthetic). The company actively drives innovation through strategic investments, such as its partnership with Balanced Pharma to develop less painful and non-opioid analgesic solutions, further cementing its position at the forefront of dental pain management.
Latest Market Research Report on Dental Anesthetics Download PDF Brochure Now
Dentsply Sirona
Dentsply Sirona Inc., headquartered in the US, is the world’s largest manufacturer of professional dental products and technologies, holding the second-largest share of the global dental anesthetics market in 2024. The company operates through several divisions, providing integrated solutions across four main segments. Dental anesthetics are offered under its Essential Dental Solutions segment, where Dentsply Sirona supplies a diverse range of materials and tools necessary for routine procedures and complex surgeries, including endodontic and restorative materials, curing lights, and diagnostic systems. By leveraging its global distribution network, the company serves dental and healthcare professionals in nearly 150 countries. Dentsply Sirona continues to focus on strategic execution and expanding its offerings to streamline clinical workflows and improve patient outcomes, reinforced by its position as a major provider of dental anesthesia and associated technologies.
Pierrel SpA
Pierrel SpA, an Italian company, is a prominent global supplier of pharmaceutical services with a specialized focus on the dental local anesthetics market, where it held the third-largest global market share in 2024. The company’s core activities include the development, manufacturing, licensing, and registration of synthetic medications and medical devices for oral health, alongside producing pharmaceutical specialties for third-party clients. Pierrel is best known for its proprietary dental anesthetic brand, Orabloc. Orabloc is distributed extensively across key international markets, including the US, Canada, Europe, and Russia, operating in 68 countries worldwide. Pierrel plays a crucial role in enhancing dental care accessibility by continually working on formulation development, such as creating patient-friendly, long-acting anesthetic solutions. This focus on specialized manufacturing and global licensing has positioned Pierrel as a critical player driving innovation in the international dental pain management landscape.
Henry Schein, Inc.
Henry Schein, Inc. is a major global distributor and provider of comprehensive healthcare products and services, acting as a crucial link in the dental anesthetics supply chain. While primarily a distributor, Henry Schein is a key market participant known for offering an extensive portfolio of dental anesthetics and anesthesia products to support pain-free dentistry for practitioners worldwide. The company features products from leading suppliers, such as Septodont’s Septocaine, and also markets its own Henry Schein Brand of high-quality dental anesthetic products at affordable prices. Beyond consumables, Henry Schein offers various practice management solutions, equipment, and technology, including partnerships for computer-controlled delivery systems. Its robust distribution network and commitment to supplying a wide array of anesthetic solutions make it indispensable for dental clinics and hospitals globally, driving the widespread availability and adoption of effective pain management tools.
Milestone Scientific
Milestone Scientific is a technology company focusing on the development and marketing of computer-controlled injection technologies, making it a critical innovator in the dental anesthetics delivery space. The company is renowned for pioneering solutions that address the issues of injection pain and prolonged soft-tissue numbness associated with traditional dental injections. Its flagship product in this market is the STA Single Tooth Anesthesia System (Wand), which utilizes Computer-Controlled Local Anesthetic Delivery (CCLAD) to deliver anesthetic solutions with greater precision, flow control, and predictability. This technology significantly enhances the patient experience by reducing discomfort and accelerating the onset of anesthesia, thereby improving procedural efficiency for clinicians. Milestone Scientific’s innovations, including recent collaborations aimed at improving distribution of its systems, are transforming the delivery methods for dental anesthetics and propelling market advancements toward patient-friendly, digital solutions.
Latest Market Research Report on Dental Anesthetics Download PDF Brochure Now